GCTK Earnings

Quarterly EPS
$-16363.95
Q3 2024
$-8555.36
Q4 2024
$-602.10
Q1 2025
$-144.30
Q2 2025
$-69.60
Q3 2025
$-59.08
Q4 2025
$-39.75
Q1 2026
$-11.40
Q2 2026
Latest RevenueN/A
Latest Net Income-3814000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$11.400-3814000—+92.1%
Q1 2026-$39.750-4334000—+93.4%
Q4 2025-$59.080-3628000—+99.3%
Q3 2025-$69.600-4171000—+99.6%
Q2 2025-$144.300-4756000—+99.0%
Q1 2025-$602.100-6833000—+94.3%
Q4 2024-$8,555.360-10094000—-131.1%
Q3 2024-$16,363.950-5087000—-85.5%
Q2 2024-$14,760.000-4489000——
Q1 2024-$10,557.000-2927000——
Q4 2023-$3,702.450-2412000——
Q3 2023-$8,820.000-2223000——
GlucoTrack (GCTK) — Earnings